Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.04% | 307.52k | 528.94k |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.39% | 117k | 201.24k |
| Vanguard Extended Market Index Fund | 0.32% | 93.83k | 161.39k |
| Fidelity Extended Market Index Fund | 0.13% | 39.5k | 67.95k |
| iShares Micro Cap ETF | 0.09% | 26.48k | 45.55k |
| Fidelity Series Total Market Index Fund | 0.04% | 11.53k | 19.83k |
| Fidelity Total Market Index Fund | 0.04% | 11.27k | 19.39k |
| Vanguard Institutional Index-Inst Total Stock Market Ind | 0.03% | 8.91k | 15.32k |
| Fidelity NASDAQ Composite Index Fund | 0.02% | 4.78k | 8.23k |
| EQ Advisors Trust-1290 VT Micro Cap Port | 0.01% | 1.83k | 3.14k |
Telesis Bio Announces Reverse Stock Split
05/06 04:05 pm
GlobeNewswire Inc.
Read moreTelesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
03/28 04:05 pm
GlobeNewswire Inc.
Read moreCytokinetics (CYTK) Reports Q4 Loss, Misses Revenue Estimates
02/27 06:10 pm
Zacks Investment Research
Read moreTelesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
02/26 10:15 am
GlobeNewswire Inc.
Read moreWhat Makes a Winning Penny Stocks Trading Strategy
02/25 07:33 am
PennyStocks
Read moreTelesis Bio Reports Third Quarter 2023 Financial Results
11/13 05:22 pm
GlobeNewswire Inc.
Read moreTelesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023
11/07 10:00 am
GlobeNewswire Inc.
Read moreTelesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
11/03 12:00 pm
GlobeNewswire Inc.
Read moreTelesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS
09/28 03:48 pm
GlobeNewswire Inc.
Read moreTelesis Bio Appoints William J. Kullback Chief Financial Officer
08/29 04:05 pm
GlobeNewswire Inc.
Read morePfizer Collaboration Offers Potential Milestone Windfalls For TBIO, Despite Financial Hurdles: Analyst
08/11 03:09 pm
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For August 11, 2023
08/11 11:00 am
Benzinga
Read moreJanux Therapeutics, Inc. (JANX) Reports Q2 Loss, Misses Revenue Estimates
08/08 05:40 pm
Zacks Investment Research
Read moreTelesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023
08/03 05:00 pm
GlobeNewswire Inc.
Read moreTelesis Bio to Present at Jefferies Healthcare Conference 2023
06/08 09:05 am
GlobeNewswire Inc.
Read moreTelesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
06/06 03:00 am
GlobeNewswire Inc.
Read moreTelesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock
06/05 05:30 pm
GlobeNewswire Inc.
Read moreTelesis Bio Secures Financing of $28.0 Million
05/31 05:29 pm
GlobeNewswire Inc.
Read moreTelesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit
05/22 12:00 pm
GlobeNewswire Inc.
Read moreTelesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit
05/18 10:00 am
GlobeNewswire Inc.
Read moreTelesis Bio (TBIO) Reports Q1 Loss, Misses Revenue Estimates
05/11 05:25 pm
Zacks Investment Research
Read moreEmergent Biosolutions (EBS) Reports Q1 Loss, Tops Revenue Estimates
05/09 06:15 pm
Zacks Investment Research
Read moreBeat the Market the Zacks Way: Hershey's, Telesis Bio, General Mills in Focus
04/17 07:50 am
Zacks Investment Research
Read moreTelesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up
03/31 09:00 am
GlobeNewswire Inc.
Read moreTelesis Bio (TBIO) Reports Q4 Loss, Tops Revenue Estimates
03/21 05:25 pm
Zacks Investment Research
Read moreTelesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
03/21 04:05 pm
GlobeNewswire Inc.
Read moreParatek Pharmaceuticals (PRTK) Reports Q4 Loss, Tops Revenue Estimates
03/16 08:55 am
Zacks Investment Research
Read moreTelesis Bio to Present at Festival of Biologics Conference
03/16 06:00 am
GlobeNewswire Inc.
Read moreTelesis Bio s'apprête à réaliser des présentations lors du RNA Leaders Europe Congress
03/14 03:16 pm
GlobeNewswire Inc.
Read moreTelesis Bio präsentiert auf dem RNA Leaders Europe Kongress
03/14 03:16 pm
GlobeNewswire Inc.
Read moreShould You Buy Telesis Bio (TBIO) After Golden Cross?
03/14 09:55 am
Zacks Investment Research
Read moreTelesis Bio to Present at RNA Leaders Europe Congress
03/14 06:00 am
GlobeNewswire Inc.
Read moreTelesis Bio to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 21, 2023
03/09 05:30 pm
GlobeNewswire Inc.
Read moreEvogene (EVGN) Reports Q4 Loss, Tops Revenue Estimates
03/09 09:45 am
Zacks Investment Research
Read moreAcadia Pharmaceuticals (ACAD) Reports Q4 Loss, Tops Revenue Estimates
02/27 06:25 pm
Zacks Investment Research
Read moreTelesis Bio Releases BioXp® Select mRNA Synthesis Kit to Expand the Utility, Speed, and Impact of Its Automated Synthetic Biology Workstation
02/16 10:00 am
GlobeNewswire Inc.
Read moreSanofi (SNY) Skin Disorder Drug Misses Goal in Phase III Study
09/09 10:47 am
Zacks Investment Research
Read moreTranslate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
09/08 04:30 pm
GlobeNewswire Inc.
Read moreSanofi (SNY) to Buy Kadmon for $1.9B, Add cGVHD Drug Rezurock
09/08 09:48 am
Zacks Investment Research
Read moreWhy Kadmon Holdings Stock Is Rocketing Higher Today
09/08 08:38 am
The Motley Fool
Read more